Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1949 1
1955 1
1958 1
1959 2
1961 1
1962 1
1965 1
1968 1
1969 1
2009 2
2010 3
2011 5
2012 4
2013 3
2014 4
2015 7
2016 10
2017 7
2018 9
2019 3
2020 12
2021 15
2022 11
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

106 results

Results by year

Filters applied: . Clear all
Page 1
The impact of the Covid-19 pandemic on breast cancer early detection and screening.
Breast Screening Working Group (WG2) of the Covid-19 and Cancer Global Modelling Consortium; Figueroa JD, Gray E, Pashayan N, Deandrea S, Karch A, Vale DB, Elder K, Procopio P, van Ravesteyn NT, Mutabi M, Canfell K, Nickson C. Breast Screening Working Group (WG2) of the Covid-19 and Cancer Global Modelling Consortium, et al. Among authors: van ravesteyn nt. Prev Med. 2021 Oct;151:106585. doi: 10.1016/j.ypmed.2021.106585. Epub 2021 Jun 30. Prev Med. 2021. PMID: 34217412 Free PMC article.
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.
van Prooyen Schuurman L, Sistermans EA, Van Opstal D, Henneman L, Bekker MN, Bax CJ, Pieters MJ, Bouman K, de Munnik S, den Hollander NS, Diderich KEM, Faas BHW, Feenstra I, Go ATJI, Hoffer MJV, Joosten M, Komdeur FL, Lichtenbelt KD, Lombardi MP, Polak MG, Jehee FS, Schuring-Blom H, Stevens SJC, Srebniak MI, Suijkerbuijk RF, Tan-Sindhunata GM, van der Meij KRM, van Maarle MC, Vernimmen V, van Zelderen-Bhola SL, van Ravesteyn NT, Knapen MFCM, Macville MVE, Galjaard RH; Dutch NIPT consortium. van Prooyen Schuurman L, et al. Among authors: van ravesteyn nt. Am J Hum Genet. 2022 Jun 2;109(6):1140-1152. doi: 10.1016/j.ajhg.2022.04.018. Am J Hum Genet. 2022. PMID: 35659929 Free PMC article.
Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP, Geuzinge HA, Stout NK, Alagoz O, Hampton J, Kerlikowske K, de Koning HJ, Miglioretti DL, van Ravesteyn NT, Schechter C, Sprague BL, Tosteson ANA, Trentham-Dietz A, Weaver D, Yaffe MJ, Yeh JM, Couch FJ, Hu C, Kraft P, Polley EC, Mandelblatt JS, Kurian AW, Robson ME; Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET), in collaboration with the Breast Cancer Surveillance Consortium (BCSC), and the Cancer Risk Estimates Related to Susceptibility (CARRIERS) Consortium. Lowry KP, et al. Among authors: van ravesteyn nt. JAMA Oncol. 2022 Apr 1;8(4):587-596. doi: 10.1001/jamaoncol.2021.6204. JAMA Oncol. 2022. PMID: 35175286 Free PMC article.
Clinical impact of additional findings detected by genome-wide non-invasive prenatal testing: Follow-up results of the TRIDENT-2 study.
van Prooyen Schuurman L, Sistermans EA, Van Opstal D, Henneman L, Bekker MN, Bax CJ, Pieters MJ, Bouman K, de Munnik S, den Hollander NS, Diderich KEM, Faas BHW, Feenstra I, Go ATJI, Hoffer MJV, Joosten M, Komdeur FL, Lichtenbelt KD, Lombardi MP, Polak MG, Jehee FS, Schuring-Blom H, Stevens SJC, Srebniak MI, Suijkerbuijk RF, Tan-Sindhunata GM, van der Meij KRM, van Maarle MC, Vernimmen V, van Zelderen-Bhola SL, van Ravesteyn NT, Knapen MFCM, Macville MVE, Galjaard RH; Dutch NIPT consortium. van Prooyen Schuurman L, et al. Among authors: van ravesteyn nt. Am J Hum Genet. 2022 Jul 7;109(7):1344. doi: 10.1016/j.ajhg.2022.06.003. Am J Hum Genet. 2022. PMID: 35803237 Free PMC article. No abstract available.
A public-private partnership model for COVID-19 diagnostics.
Krijger PHL, Hoek TA, Boersma S, Donders LIPM, Broeders MMC, Pieterse M, Toonen PW, Logister I, Verhagen BMP, Verstegen MJAM, van Ravesteyn TW, Roymans RJTM, Mattiroli F, Vandesompele J, Nijhuis M, Meijer S, van Weert A, Dekker E, Dom FJ, Ruijtenbeek R, van der Velden LBJ, van de Bovenkamp JHB, Bosch M, de Laat W, Tanenbaum ME. Krijger PHL, et al. Among authors: van ravesteyn tw. Nat Biotechnol. 2021 Oct;39(10):1182-1184. doi: 10.1038/s41587-021-01080-6. Nat Biotechnol. 2021. PMID: 34584248 No abstract available.
More on screening mammography.
van Ravesteyn NT, Heijnsdijk EA, de Koning HJ. van Ravesteyn NT, et al. N Engl J Med. 2011 Jan 20;364(3):282-3; author reply 285-6. doi: 10.1056/NEJMc1011881. N Engl J Med. 2011. PMID: 21247323 No abstract available.
Reply to Koleva-Kolarova et al.
de Koning HJ, Alagoz O, Schechter CB, van Ravesteyn NT. de Koning HJ, et al. Among authors: van ravesteyn nt. Breast. 2016 Jun;27:182-3. doi: 10.1016/j.breast.2016.01.005. Epub 2016 Mar 2. Breast. 2016. PMID: 26946960 No abstract available.
Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts.
Trentham-Dietz A, Alagoz O, Chapman C, Huang X, Jayasekera J, van Ravesteyn NT, Lee SJ, Schechter CB, Yeh JM, Plevritis SK, Mandelblatt JS; Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET). Trentham-Dietz A, et al. Among authors: van ravesteyn nt. PLoS Comput Biol. 2021 Jun 17;17(6):e1009020. doi: 10.1371/journal.pcbi.1009020. eCollection 2021 Jun. PLoS Comput Biol. 2021. PMID: 34138842 Free PMC article. Review.
106 results